Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Camp4 Therapeutics (CAMP) Revenue (2023 - 2026)

Camp4 Therapeutics' Revenue history spans 3 years, with the latest figure at $348000.0 for Q4 2025.

  • On a quarterly basis, Revenue fell 46.63% to $348000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $3.5 million, a 436.5% increase, with the full-year FY2025 number at $3.5 million, up 436.5% from a year prior.
  • Revenue hit $348000.0 in Q4 2025 for Camp4 Therapeutics, down from $795000.0 in the prior quarter.
  • Over the last five years, Revenue for CAMP hit a ceiling of $1.5 million in Q2 2025 and a floor of $348000.0 in Q4 2025.
  • Historically, Revenue has averaged $750000.0 across 3 years, with a median of $723500.0 in 2024.
  • The widest YoY moves for Revenue: up 46.63% in 2025, down 46.63% in 2025.
  • Tracing CAMP's Revenue over 3 years: stood at $350000.0 in 2023, then soared by 86.29% to $652000.0 in 2024, then tumbled by 46.63% to $348000.0 in 2025.
  • Business Quant data shows Revenue for CAMP at $348000.0 in Q4 2025, $795000.0 in Q3 2025, and $1.5 million in Q2 2025.